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Abstract
Critically ill adult patients often require multiple examinations in the hospital and need transport from one
department to another, or even between hospitals. However, to date, no guidelines exist regarding optimum
practices for transport of these fragile patients. We present recommendations for intrahospital transport of critically
ill patients, excluding newborns, developed by an expert group of the French-Language Society of Intensive Care
(Société de Réanimation de Langue Française (SRLF), the Société Française d’Anesthésie et de Réanimation (SFAR),
and the Société Française de Médecine d’Urgence (SFMU). The recommendations cover five fields of application:
epidemiology of adverse events; equipment, monitoring, and maintenance; preparation of patient before transport;
human resources and training for caregivers involved in transport processes; and guidelines for planning, structure,
and traceability of transport processes.
Keywords: intrahospital transport, critical care, adults
Introduction and methodology of the expert
recommendations
These recommendations were developed by a Working
Group brought together at the initiative of the French-
Language Society of Intensive Care (Société de Réanima-
tion de Langue Française (SRLF)). The experts compris-
ing this group wrote a background text justifying each
of the five fields of application that were previously
defined by the Organizing Committee. The recommen-
dations for pediatric patients were included in the rele-
vant fields alongside the recommendations for adults.
These expert recommendations constitute a contribu-
tion to the standard risk evaluation protocol and to the
quality of care improvement program elaborated by pro-
fessional societies in our discipline. The recommenda-
tions are mainly based on data from prospective or
retrospective observational studies and international
consensus documents. The recommendations are pro-
posed and discussed individually, with each expert (or
expert subgroup) obliged to provide scientific evidence
to justify the basis for the recommendation, as well as
the level of recommendation, each of which was subject
to modification according to the remarks made by the
rest of the expert group. In a second phase, the recom-
mendations were graded by the whole expert group.
The objective was not necessarily to arrive at a single
consensus on the level and grade of recommendation
for all the guidelines but rather to clearly identify areas
where opinions converged, which would be the basis for
the recommendations, as well as areas where
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disagreement persisted, which could be the object of
further research.
Each recommendation was graded by each expert
according to the RAND/UCLA appropriateness rating
method, using repeated rounds of grading after exclu-
sion of the extreme values (highly deviant expert rat-
ings). Each expert graded recommendations based on a
scale from 1 to 9 (with 1 corresponding to the existence
of “total disagreement, “ “absence of proof, “ or “formal
contraindication” and 9 corresponding to “total agree-
ment, “ “formal proof, “ or “formal indication”).
Three zones were defined according to the location of
the median score: 1-3 corresponds to the disagreement
zone; 4-6 to the zone of indecision; and 7-9 to the
agreement zone. The level of agreement, indecision, or
disagreement is considered to be “strong” if the median
falls within the boundaries of the corresponding zone. If
the medial overlaps with a boundary (e.g., interval from
1-4 or 6-8), then the agreement (or disagreement) is
considered to be weak. The methodology for this docu-
ment is based on the GRADE method http://www.gra-
deworkinggroup.org//links.htm.
The originality of the GRADE system resides in the
following elements: the type of study design (i.e., rando-
mized, controlled trials, or not) alone is not sufficient to
attribute a level of evidence; the actual risk-benefit ratio
is taken into account, and finally, recommendations are
formulated clearly and unambiguously for users (we
recommend/we do not recommend; we suggest/we do
not suggest).
Field 1
Epidemiology of adverse events related to patients and
their environment: general taxonomy
1) Critically ill patients, whether or not they are hospita-
lized in critical care, frequently require intrahospital
transport (IHT) for diagnostic or therapeutic proce-
dures, or for admission to a specialized care unit. Strong
Agreement.
2) Critically ill patients include all patients presenting
with dysfunction or failure or one or more vital organs
or systems. Strong Agreement.
3) It is necessary to standardize the definitions of
adverse events (AE) and their avoidance during IHT.
Strong Agreement.
4) Adverse events are classified into two categories,
according to their seriousness: serious adverse events
(SAEs), and high-risk events (HREs). Strong Agreement.
5) An SAE is a complication directly related to patient
care that can lead to a life-threatening situation, longer
hospital stay, need for invasive procedures, or have ser-
ious consequences. Strong Agreement.
6) High-risk events are defined by current legislation
for the accreditation of physicians practicing in at-risk
disciplines. They cover all adverse events that are not
SAE, i.e., minor adverse events and dysfunctions in
equipment or organization of care. Strong Agreement.
7) Minor incidents without major consequences regu-
larly occur during transport. Therefore, it is necessary to
define the most common SAE and HRE to implement
monitoring and corrective measures. Strong Agreement.
8) Adverse events that occur during transport and
require curative therapeutic intervention must be con-
sidered SAEs. Strong Agreement.
9) Adverse events that occur during transport and
require therapeutic intervention that does not succeed
in correcting the situation according to the objectives
laid down by the clinician must be considered as SAEs.
Strong Agreement.
10) A HRE complicated by auto-extubation and/or
cardiac arrest is a SAE. Strong Agreement.
11) Oxygen desaturation that requires an increase of
fractional inspired oxygen (FIO2) or any other change in
ventilator settings is considered a HRE. This should be
considered a SAE if the situation remains uncorrected
or does not reach the target set by the clinician. Strong
Agreement.
12) A decrease in blood pressure that requires thera-
peutic intervention is a HRE. This should be considered
a SAE if treatment does not reach the target set by the
clinician. Strong Agreement.
13) A state of agitation or when the patient is not syn-
chronized to the ventilator, a state that requires thera-
peutic intervention is considered a HRE. This should be
considered a SAE if the situation remains uncorrected
by the therapeutic intervention. Strong Agreement.
14) Any ventilator-related event that requires a change
in ventilatory settings, ventilation with manual resuscita-
tor (bag valve mask), or a change of equipment is con-
sidered a HRE. Strong Agreement.
15) Any ventilator-related event complicated by a clin-
ical event is considered a SAE. Strong Agreement.
16) Disconnection of equipment (catheters, drains,
intracranial pressure wires...) are considered HREs when
they have no direct clinical consequences. They must be
considered SAEs if a complication occurs. Strong
Agreement.
17) An adverse event that occurs during IHT must be
considered unavoidable when the entire transport pro-
cess was performed in conformity with standard proto-
col. Strong Agreement.
18) Safety practices are any healthcare, structural, or
organizational practices that contribute to preventing,
reducing the frequency of, or attenuating the conse-
quences of errors and adverse events during IHT.
Strong Agreement.
19) Any adverse event that occurs during IHT should
be notified for subsequent analysis. Strong Agreement.
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Field 2
Equipment, monitoring and maintenance
1) The choice of equipment should take into account its
bulk and autonomy. Strong Agreement.
2) All connections between the various monitors (e.g.,
invasive pressure wires) should be checked thoroughly
before IHT. Strong Agreement.
3) The minimum monitoring required during IHT
includes ECG heart rate monitoring, pulse oximetry,
and noninvasive blood pressure monitoring. Strong
Agreement.
4) In nonventilated patients, ventilatory rate should be
monitored at regular intervals, ideally with continuous
monitoring. Strong Agreement.
5) End-tidal CO2 (ET CO2) monitoring is recom-
mended for patients with neurological disorders and for
patients in whom strict control of partial pressure of
CO2 (PaCO2) is required. Strong Agreement.
6) The main parameters being monitored should be
associated with alarms whose settings can be adapted in
each patient. Strong Agreement.
7) Special equipment should be available, dedicated to
IHT, and clearly identified within each healthcare estab-
lishment, department, or division. Strong Agreement.
8) Ventilators used for transport should be equipped
with visual or audible alarms for the main ventilatory
parameters being monitored. Strong Agreement.
9) For ventilated patients undergoing transport that
could be of long duration, or in patients at particularly
high risk, a suction system should be immediately avail-
able, ideally in the form of a portable electric suction
device. Strong Agreement.
10) The autonomy of all devices, in terms of electricity
and medical gas supply, should be adapted to the esti-
mated duration of IHT and rate of consumption, which
can vary depending on usage, and reserves should be
monitored. Strong Agreement.
11) Monitoring equipment should be adapted to the
type of transport, patient risk, and ongoing therapy, and
based on a written protocol. Strong Agreement.
12) Manual ventilation with a manual resuscitator (bag
valve mask) during IHT should be avoided and only
used in case of failure of the ventilator (including in
children). Strong Agreement.
13) The settings on portable ventilators for use during
transport should allow for the same ventilatory para-
meters as the ICU ventilator, including noninvasive ven-
tilation modes. Strong Agreement.
14) At all times during transport, it should be possible,
in ventilated patients, to switch immediately from venti-
lation to manual ventilation through an endotracheal
tube or mask. Strong Agreement.
15) The exact capacities of the portable ventilator for
use during transport should be known to the user.
There are three categories. Strong Agreement.
- Basic or emergency ventilators (volume-control
(VC) mode, positive end-expiratory pressure (PEEP),
reduced monitoring)
- Intermediate ventilator (volume assist control
(VAC), PEEP, adjustable flow or I:E ratio, spirome-
try), FiO2 setting at 100% or air/oxygen mix
- High-performance ventilator (volumetric and baro-
metric ventilation modes, including spontaneous
mode and assist control, PEEP, wide range of set-
tings for FiO2, adjustable inspiratory flow, appropri-
ate triggers, spirometry, ideally with circuit
compliance compensation and non-invasive ventila-
tion (NIV) mode).
16) The functions, monitoring, and alarms on the ven-
tilator should be adapted to the patient’s condition.
Strong Agreement.
- A. Very hypoxemic patient (e.g., acute respiratory
distress syndrome): high-performance ventilator
- B. Patient requiring strict control of PaCO2: inter-
mediate or high-performance ventilator
- C. Patient-triggered ventilation (assist modes): inter-
mediate or high-performance ventilator
- D. Patients under noninvasive ventilation: Ventilator
with a high-performance NIV mode
17) The type of electric supply and recharging capabil-
ities of the ventilator must be compatible with use at all
times and should have sufficient electricity reserves to
perform the planned IHT. Strong Agreement.
18) The ventilator used for IHT must have an audible
alarm to signal interruption of gas or electricity supply,
or ventilator failure. Strong Agreement.
19) The interface of the portable ventilator used for
transport should not allow for any accidental distur-
bances to the ventilator settings. Strong Agreement.
20) At equal performance levels. Strong Agreement
- The ventilator with the simplest user interface
should be given precedence.
- The ventilator with the simplest patient circuit
should be given precedence.
21) To check that tolerance of the portable ventilator
and patient stability are adequate, the portable ventilator
should be connected to the patient 5 to 10 minutes
before leaving the patient’s room, using the wall gas
supply and the mains electricity supply. Strong
Agreement.
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22) The portable ventilator should be stored in an
easily accessible place that is known to all potential
users and with all accessories: complete patient circuit
kit with heat and moisture exchanger (HME) and corru-
gated tube, gas supply tube. Strong Agreement.
23) The circuit used should be in accordance with
manufacturer’s recommendations. Strong Agreement.
24) Where necessary, the ventilator tubes used should
be adapted to the characteristics of the ventilator.
Strong Agreement.
25) To ensure adequate humidification of the patient’s
airways and protection of the ventilator, an antibacterial
filter and HME should be systematically put in place
between the corrugated tube and the patient circuit.
Strong Agreement.
26) The machine settings and alarms for the portable
ventilator must be specified on a written prescription.
Strong Agreement.
27) Ventilation monitoring by the portable ventilator
should comprise, as a minimum requirement, monitor-
ing of inspiratory pressure with display of the peak pres-
sure and spirometry. Strong Agreement.
28) Self- or accidental extubation must be detected
immediately by monitoring of capnography and/or
spirometry. Strong Agreement.
29) Analysis of the expiratory phase of the capnogram
can help to identify certain complications of ventilation
during transport. Strong Agreement.
30) In synchronous intermittent mandatory ventilation
(SIMV) mode, the portable ventilator should be
equipped with the necessary general requirements in
terms of performance and monitoring to guarantee
appropriate ventilation. Strong Agreement.
31) Certain models of portable ventilator claim to be
equipped with SIMV mode but in actual fact do not
really provide this mode of ventilation. These ventilators
should not be used. Strong Agreement.
32) Continuous positive airway pressure (CPAP) mode
is suboptimal on ventilators and consumes large
amounts of oxygen. Strong Agreement.
33) An invasive device for continuous measurement of
blood pressure must be used during IHT if the patient
is under treatment with vasoactive agents and/or hemo-
dynamically unstable, and if the patient already has con-
tinuous invasive blood pressure monitoring in the
hospital before IHT. Strong Agreement.
34) Monitoring of central venous pressure is not
recommended during IHT. Strong Agreement.
35) A defibrillator-pacemaker must be easily available
during transport. Ideally, it should be integrated with a
multiparameter monitor. Strong Agreement.
36) If the patient is dependent on an external pace-
maker, the thresholds of the pacemaker must be verified
and adapted, and the battery should be checked. A
spare external pacemaker must be available during
transport. Strong Agreement.
37) In the presence of temporary pacing wires, a por-
table pacemaker must be used. Strong Agreement.
38) A written protocol must be put in place to plan
for the immediate replacement of any defective or miss-
ing equipment. Strong Agreement.
39) The equipment used for IHT must be controlled
regularly against to a predefined checklist. Strong
Agreement.
40) After use, the ventilator must be cleaned and dis-
infected according to a written protocol. Strong
Agreement.
41) During IHT of pediatric patients, a complete kit
comprising resuscitation equipment and drugs for chil-
dren must accompany the patient, particularly a self-
inflating bag, a face mask, and an intubation kit adapted
to the age of the child, as well as an intraosseous cathe-
terization kit. Strong Agreement.
42) Monitoring of EtCO2 is recommended during
transport in case of manual ventilation of an intubated
child to prevent hyperventilation. Strong Agreement.
43) For the transport of children < 15 kg, it is manda-
tory to have a ventilator that can deliver low tidal
volumes, ensure high frequencies, and maintain PEEP.
Strong Agreement.
44) The size and compliance of the tubes used should
be adapted to the age and weight of the child to mini-
mize the compressible volume (small tubes for body-
weight < 15 kg). Strong Agreement.
Field 3
Preparation of the patient before transport
1) Before IHT, evaluation of the clinical status of the
patient and the risk-benefit ratio must be performed.
The results of these evaluations must be recorded in the
patient’s medical file. Strong Agreement.
2) It is mandatory to check for the absence of contra-
indications to complementary procedures. Strong
Agreement.
3) The patient must be wearing an identification
wristband. Strong Agreement.
4) At least one permeable venous access is required,
and if necessary, an additional access line specifically
reserved for amines and clearly identified as such. All
access lines (central or peripheral) should be clean and
firmly attached. Strong Agreement.
5) Electric syringe pumps should be clearly identified
and the quantity of drugs adapted to the duration of
transport. The electricity supply cables should be avail-
able during transport. Electric syringe pumps should
be plugged back into a mains supply as soon as possi-
ble (as should all other electric material). Strong
Agreement.
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6) For patients who require strict control of PaCO2,
an arterial sample should be taken before IHT to mea-
sure PaCO2 gradient and EtCO2. Strong Agreement
7) Cerebral perfusion pressure should continue to be
monitored during transport of neurology patients.
Strong Agreement.
8) The optimal patient position in critical care should
be maintained during IHT. Strong Agreement.
9) Any pain that could be induced by IHT and/or the
procedures to be performed should be anticipated, eval-
uated, and treated. Strong Agreement.
10) Sedation and/or analgesia should be maintained
during transport and can be modified if necessary.
Strong Agreement.
11) Mobilization of curarized patients should be the
object of particular caution. Strong Agreement.
12) A complete intubation kit (including Eschmann
tracheal tube introducer) should be immediately avail-
able. Strong Agreement.
13) Each time the patient is mobilized, a thorough
verification of the correct positioning of all invasive
devices should be performed. Strong Agreement.
14) A manual resuscitator (bag valve mask) with
appropriate mask, oxygen reservoir, oxygen extension
tube, and spare filter must accompany the patient dur-
ing IHT. Strong Agreement.
15) Hypothermia during IHT must be avoided, parti-
cularly in children, by monitoring temperature. Strong
Agreement.
16) Disposable equipment should be preferred. Strong
Agreement.
17) The balloon pressure of the intratracheal tube
should be verified before IHT and after IHT. Strong
Agreement.
18) An emergency intervention kit should accompany
the patient during transport. Strong Agreement.
Field 4
Caregivers: human resources and training
1) Initial and regular training is mandatory for all staff
providing IHT, both in the use of equipment and its
monitoring (ventilator, multiparametric monitors, defi-
brillator...). Strong Agreement.
2) Special initial and regular training is required for all
medical and paramedical staff performing transport of
pediatric patients < 15 kg. Strong Agreement.
3) Training of staff responsible for IHT can be pro-
vided in the form of simulations of transport situations.
Strong Agreement.
4) Evaluation of risk and the specific modalities of
IHT are the responsibility of the senior physician in
charge of the patient. Strong Agreement.
5) The transport team for a critically ill patient must
include at least one experienced physician and one staff
member specially trained in IHT procedures. Strong
Agreement.
6) A procedure for activating emergency aid (medical
or nursing backup) should be available and known to all
staff members, in case of any problem occurring during
IHT. Strong Agreement.
7) An infusion specialized, or qualified equivalent,
must be included in the IHT team when the patient is
under extracorporeal circulation. Strong Agreement.
8) If the mobile medical emergency unit is responsible
for performing IHT, then they should receive a full
briefing on the status of the patient from the senior
physician in charge of the patient, as well as a written
report. Strong Agreement.
Field 5
Organization (planning), structure, and traceability
1) The exact time, meeting point, and duration of
immobilization of the patient must be specified and
checked before initiating IHT. Strong Agreement.
2) The name of the physician and the technical facil-
ities available at the destination must be known in
advance. Strong Agreement.
3) Before initiating IHT, the planned route must be
mapped out and known to the transport staff, with
knowledge of the accessibility of corridors and elevators,
giving precedence to the shortest and safest route possi-
ble. Strong Agreement.
4) The destination department must be informed of
the patient’s imminent arrival. Strong Agreement.
5) The traceability of the variables monitored during
IHT must be specifically recorded on a monitoring
sheet that must subsequently be integrated into the
patient’s medical file. Strong Agreement.
6) A paper printout of traceability data (data moni-
tored during IHT) is preferable. Strong Agreement.
7) If the physician that receives the patient at the
destination is qualified to monitor the patient, the
IHT team should transfer all necessary information to
this physician to ensure continued care. Strong
Agreement.
8) In the absence of a physician qualified to monitor
the patient at the destination, the IHT team will remain
in charge of monitoring the patient. Strong Agreement.
9) The organization of IHT must be laid down in an
institutional protocol. Strong Agreement.
10) IHT should be taken into account and coded in
the same way as other elements of clinical activity.
Strong Agreement.
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